Skip to main content
. 2019 Apr 18;19:113. doi: 10.1186/s12877-019-1114-2

Table 3.

Use of alcohol and prescribed drugs in HUNT2 (1995–1997) and HUNT3 (2006–2008)

Prevalence of frequent drinking (alcohol consumption ≥ 4 days/week) among participants in HUNT2 and who participated in HUNT3 11 years later
HUNT2 HUNT3
Total (n = 7955) N (%) 83 (1.0) 297 (3.7)c***
Gender
 Women (n = 3876) N (%) 14 (0.4) 106 (2.7)c***
 Men (n = 4079) N (%) 69 (1.7) 191 (4.7)c***
Age group in HUNT2:
 53–59 years (n = 3462) N (%) 30 (0.9) 150 (4.3)c***
 60–64 years (n = 2020) N (%) 20 (1.0) 71 (3.5)c**
 ≥ 65 years (n = 2473) N (%) 33 (1.3) 76 (3.1)c**
Prevalence of use of prescribed drugs among participants in HUNT2a and who participated in HUNT3 11 years laterb
HUNT2 HUNT3
Total (n = 8691) N (%) 858 (9.9) 2354 (27.1)c***
Gender
 Female (n = 4714) N (%) 621 (13.2) 1681 (35.7)c***
 Male (n = 3977) N (%) 237 (6.0) 673 (16.9)c***
Age group in HUNT2
 53–59 years (n = 3481) N (%) 265 (7.6) 693 (19.9)c***
 60–64 years (n = 2196) N (%) 207 (9.4) 573 (26.1)c***
 ≥ 65 years (n = 3014) N (%) 386 (12.8) 1088 (36.1)c***

aInformation about prescribed drugs in HUNT2: Self-reported use of anxiolytic or sleep medication every week or more in the last month

bInformation about prescribed drugs in HUNT3: Addictive psychotropic drugs drawn from the Norwegian Prescription Database were defined as at least one prescription of benzodiazepines or z-hypnotics in two consecutive years (2005/2006, 2006/2007, 2007/2008 or 2008/2009). Benzodiazepines defined by N03AE, N05BA and N05CD. Z-hypnotics defined by N05CF

cSignificance testing with McNemar’s Exact Test

***P < 0.001